SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?


To: Oliver & Co who wrote (5604)10/29/1998 10:26:00 AM
From: Oliver & Co  Read Replies (2) | Respond to of 6136
 
"U.S. to Begin Minority AIDS Initiative"
Washington Post (10/29/98) P. A3; Goldstein, Amy
President Clinton announced a $156 million initiative focusing on
HIV/AIDS issues among minority communities on Wednesday. The
campaign is designed to create HIV-prevention programs, increase
access to drug treatment programs, and help local health workers
more effectively assess the needs of HIV-infected people. At a
White House ceremony to announce the initiative, Clinton said,
"Like other epidemics before it, AIDS is now hitting hardest in
areas where knowledge about the disease is scarce and poverty is
high. We must use all our power to end the growing disparities
in HIV and AIDS." African-Americans now constitute 45 percent of
new AIDS cases in the United States, up from 25 percent in 1986,
while Hispanics account for 22 percent of new AIDS cases, up from
14 percent. Many affected individuals cannot afford new drug
therapies that combat the virus; and while the AIDS death rate
dropped by about 50 percent overall last year, it is still the
leading cause of death among African-American men aged 25 to 44.
The Congressional Black Caucus recently called on the
administration to declare a "state of emergency" in
African-American communities in regard to the AIDS crisis. The
new plan comes as part of an $865 million increase in funding for
anti-AIDS programs by the government, bringing the total national
spending on the disease to $7.7 billion.